Genome-Wide Analysis Reveals Mucociliary Remodeling of the Nasal Airway Epithelium Induced by Urban PM(2.5).

Homo sapiens fine respirable suspended particulate matter

Study subjects

soma:montgomery-nasal-ali-doseresponse

Primary nasal AEC ALI cultures - five-donor dose-response set

type: CellularSystem Homo sapiens NCBITaxon:9606 nasal cavity respiratory epithelium epithelial cell of viscerocranial mucosa CL:2000094
soma:montgomery-nasal-ali-12donor

Primary nasal AEC ALI cultures - 12-donor moderate OE set

type: CellularSystem Homo sapiens NCBITaxon:9606 nasal cavity respiratory epithelium epithelial cell of viscerocranial mucosa CL:2000094
soma:montgomery-nasal-ali-chronic

Primary nasal AEC ALI cultures - chronic stimulation set

type: CellularSystem Homo sapiens NCBITaxon:9606 nasal cavity respiratory epithelium epithelial cell of viscerocranial mucosa CL:2000094

Gene expression assays

GE:montgomery-deg-burden-dose-series

Differentially expressed gene burden across the PM2.5 extract dose series

Paired mock-versus-treated RNA-seq across the full acute dose series in five donor cultures. Water-soluble extract produced no DEGs at either 3 or 30 ug/cm2. Organic extract produced a dose-dependent DEG burden: 11 DEGs at the low dose (0.045 ug/cm2), 124 at the moderate dose (0.45 ug/cm2) and 1,296 at the high dose (4.5 ug/cm2) - roughly a 10-fold rise in DEG count per 10-fold rise in concentration. The NIST 2786 reference material at 30 ug/cm2 gave 111 DEGs, comparable in size to the moderate OE dose. DEG counts are study-level totals rather than per-gene measurements, so they are recorded in these descriptions and no QuantityValue is invented for them.

gene expression method: Whole transcriptome RNA-seq (KAPA mRNA HyperPrep, Illumina NovaSeq 6000) normalization reference: paired mock-stimulated culture from the same donor

Exposure conditions

ConditionAgentConcentrationDuration
Mock extract control (blank filter extract), two apical stimulations 24 h apart
EXPOSURE:montgomery-mock-48h
— — 48 hour
PM2.5 water-soluble extract 3 ug/cm2, two apical stimulations 24 h apart
EXPOSURE:montgomery-we-3-48h
fine respirable suspended particulate matter
ENVO:01000415
3 microgram per square centimeter 48 hour
PM2.5 water-soluble extract 30 ug/cm2, two apical stimulations 24 h apart
EXPOSURE:montgomery-we-30-48h
fine respirable suspended particulate matter
ENVO:01000415
30 microgram per square centimeter 48 hour
PM2.5 organic extract 0.045 ug/cm2 (low dose), two apical stimulations 24 h apart
EXPOSURE:montgomery-oe-low-48h
fine respirable suspended particulate matter
ENVO:01000415
0.045 microgram per square centimeter 48 hour
PM2.5 organic extract 0.45 ug/cm2 (moderate dose), two apical stimulations 24 h apart
EXPOSURE:montgomery-oe-mod-48h
fine respirable suspended particulate matter
ENVO:01000415
0.45 microgram per square centimeter 48 hour
PM2.5 organic extract 4.5 ug/cm2 (high dose), two apical stimulations 24 h apart
EXPOSURE:montgomery-oe-high-48h
fine respirable suspended particulate matter
ENVO:01000415
4.5 microgram per square centimeter 48 hour
NIST 2786 fine particulate reference material 30 ug/cm2, two apical stimulations 24 h apart
EXPOSURE:montgomery-nist-30-48h
fine respirable suspended particulate matter
ENVO:01000415
30 microgram per square centimeter 48 hour

Outputs

GroupOutputDescription
control Mock extract control, acute stimulation
GE:montgomery-deg-burden-dose-series-output-mock · under EXPOSURE:montgomery-mock-48h
Paired mock (blank filter extract) control. All DEG counts and log2 fold changes in this file are relative to this paired control, so no absolute expression value is recorded here.
treated Water-soluble extract 3 ug/cm2
GE:montgomery-deg-burden-dose-series-output-we3 · under EXPOSURE:montgomery-we-3-48h
No genes with significantly modified expression.
treated Water-soluble extract 30 ug/cm2
GE:montgomery-deg-burden-dose-series-output-we30 · under EXPOSURE:montgomery-we-30-48h
No genes with significantly modified expression, at more than six times the highest OE dose tested.
treated Organic extract 0.045 ug/cm2 (low dose)
GE:montgomery-deg-burden-dose-series-output-oe-low · under EXPOSURE:montgomery-oe-low-48h
11 differentially expressed genes; 9 of the 11 were also DEGs at the moderate dose.
treated Organic extract 0.45 ug/cm2 (moderate dose), n=5 dose-response set
GE:montgomery-deg-burden-dose-series-output-oe-mod · under EXPOSURE:montgomery-oe-mod-48h
124 differentially expressed genes in the five-donor dose-response experiment; 71% of them were also DEGs at the high dose.
treated Organic extract 4.5 ug/cm2 (high dose)
GE:montgomery-deg-burden-dose-series-output-oe-high · under EXPOSURE:montgomery-oe-high-48h
1,296 differentially expressed genes.
treated NIST 2786 reference material 30 ug/cm2
GE:montgomery-deg-burden-dose-series-output-nist · under EXPOSURE:montgomery-nist-30-48h
111 differentially expressed genes; 35% of the moderate OE DEGs were also NIST DEGs and the LFCs of the two responses were correlated (Pearson 0.75, P = 1.68e-34).

Evidence

from 11 (low dose) to 124 (moderate dose) to 1,296 (high dose)
SUPPORT IN VITRO PMID:32275839

Gives the dose-dependent DEG counts for the three organic extract doses that this assay's three treated output records stand for.

No genes exhibited significantly modified expression with either WE stimulation concentration tested.
SUPPORT IN VITRO PMID:32275839

Supports the two water-soluble extract output records, which record a null transcriptomic response at both WE concentrations.

We also detected 111 DEGs induced by NIST 2786 stimulation, a response comparable in size to the moderate OE dose stimulation
SUPPORT IN VITRO PMID:32275839

Supports the NIST 2786 benchmark output record and its comparison with the moderate OE dose.

Experiments were conducted by performing two consecutive stimulations at the indicated concentrations 24 hours apart, with culture harvest 24 hours after the second stimulation.
SUPPORT IN VITRO PMID:32275839

Establishes the 48-hour acute exposure duration recorded on every acute exposure condition in this file.

GE:montgomery-cyp1a1-ahr-battery-mod

CYP1A1 and AHR battery enzyme expression - moderate OE dose

In the 12-donor moderate OE dose characterization (424 DEGs: 281 up, 143 down), CYP1A1 was the most highly induced gene at LFC 6.21. Other AHR-inducible xenobiotic metabolizing enzymes were also significantly induced (CYP1B1, NQO1, ALDH3A1), consistent with the PAH content of the organic extract acting through AHR-mediated transcriptional activation. The paper reports no effect sizes for CYP1B1, NQO1 or ALDH3A1 in the cached text, so only CYP1A1 carries a value.

target gene: CYP1A1 gene expression method: Whole transcriptome RNA-seq (KAPA mRNA HyperPrep, Illumina NovaSeq 6000) normalization reference: paired mock-stimulated culture from the same donor

Exposure conditions

ConditionAgentConcentrationDuration
Mock extract control (blank filter extract), two apical stimulations 24 h apart
EXPOSURE:montgomery-mock-48h
— — 48 hour
PM2.5 organic extract 0.45 ug/cm2 (moderate dose), two apical stimulations 24 h apart
EXPOSURE:montgomery-oe-mod-48h
fine respirable suspended particulate matter
ENVO:01000415
0.45 microgram per square centimeter 48 hour

Outputs

GroupOutputDescription
control CYP1A1 in paired mock-stimulated cultures
GE:montgomery-cyp1a1-ahr-battery-mod-output-mock · under EXPOSURE:montgomery-mock-48h
Paired mock control. The paper reports the response only as an LFC against this control, so no absolute value is recorded.
treated CYP1A1 at the moderate OE dose
GE:montgomery-cyp1a1-ahr-battery-mod-output-oe-mod · under EXPOSURE:montgomery-oe-mod-48h
mrna_level is the log2 fold change (LFC = 6.21) versus paired mock-stimulated cultures, not a linear fold change; no unit term for a log2 fold change exists in this repo. The most highly OE-induced gene in the 424-DEG moderate dose response.
mrna level: 6.21 (single value; n=12)

Evidence

we found that the most highly OE-induced gene was the xenobiotic metabolizing cytochrome P450 enzyme,CYP1A1(LFC, 6.21;Figure 3B)
SUPPORT IN VITRO PMID:32275839

Source of the CYP1A1 LFC of 6.21 recorded on the treated output record, and of the statement that it was the most highly induced gene. Gene symbols run into the surrounding words in the cached HTML text; the quote is copied exactly as cached.

Consistent with OE activation of the AHR receptor, we observed significant induction of other AHR-inducible xenobiotic metabolizing enzymes, includingCYP1B1and genes encoding the AHR battery enzymesNQO1
SUPPORT IN VITRO PMID:32275839

Supports reading the CYP1A1 induction as AHR pathway activation rather than an isolated gene effect, which is the key event this assay informs on.

Paired differential gene expression analysis of these donors identified 424 DEGs consisting of 281 upregulated and 143 downregulated genes
SUPPORT IN VITRO PMID:32275839

Gives the size and composition of the 12-donor moderate OE response within which the CYP1A1 and AHR battery inductions sit.

GE:montgomery-il1a-il1b-mod

IL1A and IL1B expression - moderate OE dose

IL1A (LFC 0.91) and IL1B (LFC 1.22) were among the most highly upregulated genes at the moderate OE dose. In the eight-metagroup OE response network built with FGNet, CYP1A1, IL1A and IL1B were shared across metagroups and had especially high betweenness centrality, marking the IL-1 axis as a hub of the response rather than an incidental signal. Both were further upregulated at the high OE dose.

target gene: IL1A; IL1B gene expression method: Whole transcriptome RNA-seq (KAPA mRNA HyperPrep, Illumina NovaSeq 6000) normalization reference: paired mock-stimulated culture from the same donor

Exposure conditions

ConditionAgentConcentrationDuration
Mock extract control (blank filter extract), two apical stimulations 24 h apart
EXPOSURE:montgomery-mock-48h
— — 48 hour
PM2.5 organic extract 0.45 ug/cm2 (moderate dose), two apical stimulations 24 h apart
EXPOSURE:montgomery-oe-mod-48h
fine respirable suspended particulate matter
ENVO:01000415
0.45 microgram per square centimeter 48 hour

Outputs

GroupOutputDescription
control IL1A and IL1B in paired mock-stimulated cultures
GE:montgomery-il1a-il1b-mod-output-mock · under EXPOSURE:montgomery-mock-48h
Paired mock control; responses are reported only as LFCs against it.
treated IL1A at the moderate OE dose
GE:montgomery-il1a-il1b-mod-output-il1a · under EXPOSURE:montgomery-oe-mod-48h
mrna_level is the log2 fold change (LFC = 0.91) for IL1A versus paired mock-stimulated cultures.
mrna level: 0.91 (single value; n=12)
treated IL1B at the moderate OE dose
GE:montgomery-il1a-il1b-mod-output-il1b · under EXPOSURE:montgomery-oe-mod-48h
mrna_level is the log2 fold change (LFC = 1.22) for IL1B versus paired mock-stimulated cultures.
mrna level: 1.22 (single value; n=12)

Evidence

inflammatory cytokines were both among the most highly upregulated genes with OE stimulation (LFC, 0.91 and 1.22, respectively;Figure 3B)
SUPPORT IN VITRO PMID:32275839

Source of the IL1A LFC of 0.91 and the IL1B LFC of 1.22 recorded on the treated output records.

TheCYP1A1,IL1A, andIL1Bgenes were shared by multiple metagroups and exhibited especially high betweenness centrality, indicating the likely critical nature of these genes in the transcriptional response to OE stimulation.
SUPPORT IN VITRO PMID:32275839

Supports recording the IL-1 program as a central key event of the OE response; the quote is copied exactly as cached, where gene symbols run into the adjacent words.

GE:montgomery-spdef-foxa3-mod

SPDEF and FOXA3 expression - moderate OE dose

Coexpression analysis of the OE-upregulated mucus secretory genes put SPDEF - the canonical transcription factor driving mucus production and metaplasia - at the centre of a module containing MUC5AC, BPIFA1, BPIFB1 and the ER stress factor XBP1. FOXA3, a further mucus metaplasia transcription factor, was upregulated in a different cluster. The cached text reports no LFC for SPDEF or FOXA3 at the moderate dose (the chronic-stimulation SPDEF LFC is recorded on GE:montgomery-spdef-chronic-qpcr), so these output records carry no value.

target gene: SPDEF; FOXA3 gene expression method: Whole transcriptome RNA-seq (KAPA mRNA HyperPrep, Illumina NovaSeq 6000) normalization reference: paired mock-stimulated culture from the same donor

Exposure conditions

ConditionAgentConcentrationDuration
Mock extract control (blank filter extract), two apical stimulations 24 h apart
EXPOSURE:montgomery-mock-48h
— — 48 hour
PM2.5 organic extract 0.45 ug/cm2 (moderate dose), two apical stimulations 24 h apart
EXPOSURE:montgomery-oe-mod-48h
fine respirable suspended particulate matter
ENVO:01000415
0.45 microgram per square centimeter 48 hour

Outputs

GroupOutputDescription
control SPDEF and FOXA3 in paired mock-stimulated cultures
GE:montgomery-spdef-foxa3-mod-output-mock · under EXPOSURE:montgomery-mock-48h
Paired mock control.
treated SPDEF and FOXA3 at the moderate OE dose
GE:montgomery-spdef-foxa3-mod-output-oe-mod · under EXPOSURE:montgomery-oe-mod-48h
Both upregulated; the cached text states the direction without an effect size for either gene at this dose, so no value is recorded.

Evidence

wasSPDEF(SAM pointed domain containing ETS transcription factor), a canonical TF reported to drive mucus production and metaplasia in response to the type 2 cytokine, IL-13
SUPPORT IN VITRO PMID:32275839

Identifies SPDEF as the central mucus metaplasia transcription factor in the OE-induced secretory coexpression module, the goblet cell hyperplasia key event this assay informs on.

we also observed upregulation ofFOXA3(forkhead box A3), an additional mucus metaplasia TF functionally related toSPDEF
SUPPORT IN VITRO PMID:32275839

Supports the FOXA3 output record: the paper states its upregulation without an effect size.

the most significant enrichment was for mucus secretory cell marker genes among OE-upregulated DEGs
SUPPORT IN VITRO PMID:32275839

Supports reading the SPDEF/FOXA3 induction as an expansion of the mucus secretory compartment rather than a change confined to gene expression; the paper gives this enrichment as Padj = 1.19e-74 at the moderate dose.

GE:montgomery-scgb1a1-high-oe

SCGB1A1 expression - high OE dose

The activation of mucus secretory genes at the high OE dose was matched by repression of SCGB1A1, the club secretory cell marker gene (LFC -0.92, Padj = 1.13e-3), which the paper reads as mucus metaplasia of club secretory cells of the kind reported for IL-13.

target gene: SCGB1A1 gene expression method: Whole transcriptome RNA-seq (KAPA mRNA HyperPrep, Illumina NovaSeq 6000) normalization reference: paired mock-stimulated culture from the same donor

Exposure conditions

ConditionAgentConcentrationDuration
Mock extract control (blank filter extract), two apical stimulations 24 h apart
EXPOSURE:montgomery-mock-48h
— — 48 hour
PM2.5 organic extract 4.5 ug/cm2 (high dose), two apical stimulations 24 h apart
EXPOSURE:montgomery-oe-high-48h
fine respirable suspended particulate matter
ENVO:01000415
4.5 microgram per square centimeter 48 hour

Outputs

GroupOutputDescription
control SCGB1A1 in paired mock-stimulated cultures
GE:montgomery-scgb1a1-high-oe-output-mock · under EXPOSURE:montgomery-mock-48h
Paired mock control.
treated SCGB1A1 at the high OE dose
GE:montgomery-scgb1a1-high-oe-output-oe-high · under EXPOSURE:montgomery-oe-high-48h
mrna_level is the log2 fold change (LFC = -0.92, Padj = 1.13e-3) versus paired mock-stimulated cultures.
mrna level: -0.92 (single value; n=5)

Evidence

this activation of mucus secretory genes with high OE dose stimulation was matched by repression ofSCGB1A1(secretoglobin family 1A member 1)
SUPPORT IN VITRO PMID:32275839

States the SCGB1A1 repression at the high OE dose that this assay records; the accompanying LFC of -0.92 and Padj of 1.13e-3 are given in the same sentence of the cached text.

This is consistent with mucus metaplasia of club secretory cells, as has been reported for IL-13
SUPPORT IN VITRO PMID:32275839

Supports interpreting the SCGB1A1 loss as club cell mucus metaplasia, which is the club cell marker loss key event this assay informs on.

GE:montgomery-spdef-chronic-qpcr

SPDEF expression - chronic OE stimulation, with IL-13 benchmark

Five days of repeat high-OE stimulation raised SPDEF expression (LFC 0.84, P = 3.19e-2), alongside MUC5AC upregulation - the signature of mucus metaplasia. Chronic IL-13, used as a benchmark for metaplastic expansion of mucus secretory cells, produced a larger SPDEF rise (LFC 2.91, P = 2.54e-2). The matching increase in SPDEF protein (1.5-fold) is recorded in response_comparisons as COMP:montgomery-spdef-protein-chronic.

target gene: SPDEF gene expression method: Quantitative PCR normalization reference: paired mock/media-treated culture from the same donor

Exposure conditions

ConditionAgentConcentrationDuration
Media control, five apical treatments every 24 h
EXPOSURE:montgomery-media-control-chronic
— — 120 hour
PM2.5 organic extract, high dose (Yuba City sample), five apical stimulations every 24 h
EXPOSURE:montgomery-oe-high-chronic
fine respirable suspended particulate matter
ENVO:01000415
— 120 hour
IL-13 10 ng/ml apical and basolateral, five treatments every 24 h (mucus metaplasia benchmark)
EXPOSURE:montgomery-il13-chronic
— — 120 hour

Outputs

GroupOutputDescription
control SPDEF in paired media control cultures, chronic protocol
GE:montgomery-spdef-chronic-qpcr-output-control · under EXPOSURE:montgomery-media-control-chronic
Paired media control for the chronic protocol; the paper reports only LFCs against it.
treated SPDEF after chronic OE stimulation
GE:montgomery-spdef-chronic-qpcr-output-oe · under EXPOSURE:montgomery-oe-high-chronic
mrna_level is the log2 fold change (LFC = 0.84, P = 3.19e-2) versus paired media control.
mrna level: 0.84 (single value)
treated SPDEF after chronic IL-13 stimulation (benchmark)
GE:montgomery-spdef-chronic-qpcr-output-il13 · under EXPOSURE:montgomery-il13-chronic
mrna_level is the log2 fold change (LFC = 2.91, P = 2.54e-2) versus paired media control, for the IL-13 mucus metaplasia benchmark.
mrna level: 2.91 (single value)

Evidence

We found that both chronic OE and IL-13 stimulation resulted in upregulation ofMUC5AC
SUPPORT IN VITRO PMID:32275839

Opens the sentence that reports the chronic OE and IL-13 SPDEF and MUC5AC effect sizes this assay records, for both the OE and the IL-13 output records.

characteristic of mucus metaplasia
SUPPORT IN VITRO PMID:32275839

The paper's own reading of the paired MUC5AC and SPDEF induction as mucus metaplasia, which is the goblet cell hyperplasia key event this assay informs on.

As a benchmark for metaplastic expansion of mucus secretory cells, we also performed chronic stimulations of additional cultures from the same donors with the cytokine IL-13.
SUPPORT IN VITRO PMID:32275839

Establishes the role of the IL-13 output record in this assay: a positive-control benchmark run on the same donors, not a second test article.

GE:montgomery-scgb1a1-chronic-qpcr

SCGB1A1 expression - chronic OE stimulation, with IL-13 benchmark

Chronic OE stimulation decreased SCGB1A1 expression (LFC -1.51, P = 2.94e-2), as did the IL-13 benchmark (LFC -1.74, P = 4.09e-2) - loss of club cell identity accompanying the mucus metaplasia phenotype.

target gene: SCGB1A1 gene expression method: Quantitative PCR normalization reference: paired mock/media-treated culture from the same donor

Exposure conditions

ConditionAgentConcentrationDuration
Media control, five apical treatments every 24 h
EXPOSURE:montgomery-media-control-chronic
— — 120 hour
PM2.5 organic extract, high dose (Yuba City sample), five apical stimulations every 24 h
EXPOSURE:montgomery-oe-high-chronic
fine respirable suspended particulate matter
ENVO:01000415
— 120 hour
IL-13 10 ng/ml apical and basolateral, five treatments every 24 h (mucus metaplasia benchmark)
EXPOSURE:montgomery-il13-chronic
— — 120 hour

Outputs

GroupOutputDescription
control SCGB1A1 in paired media control cultures, chronic protocol
GE:montgomery-scgb1a1-chronic-qpcr-output-control · under EXPOSURE:montgomery-media-control-chronic
Paired media control.
treated SCGB1A1 after chronic OE stimulation
GE:montgomery-scgb1a1-chronic-qpcr-output-oe · under EXPOSURE:montgomery-oe-high-chronic
mrna_level is the log2 fold change (LFC = -1.51, P = 2.94e-2) versus paired media control.
mrna level: -1.51 (single value)
treated SCGB1A1 after chronic IL-13 stimulation (benchmark)
GE:montgomery-scgb1a1-chronic-qpcr-output-il13 · under EXPOSURE:montgomery-il13-chronic
mrna_level is the log2 fold change (LFC = -1.74, P = 4.09e-2) versus paired media control.
mrna level: -1.74 (single value)

Evidence

Moreover, these stimuli resulted in decreased expression ofSCGB1A1
SUPPORT IN VITRO PMID:32275839

States the chronic OE and IL-13 decrease in SCGB1A1 that this assay records; the effect sizes follow in the same sentence of the cached text.

These results support that OE induces a mucus metaplasia process similar to IL-13
SUPPORT IN VITRO PMID:32275839

The paper's conclusion from the chronic qPCR panel, supporting the club-cell-loss reading of the SCGB1A1 decrease.

Goblet cell assays

GCM:montgomery-mucin-transcripts-acute

Gel-forming mucin transcripts and MUC5AC/MUC5B ratio - acute OE dose series

MUC5AC was strongly induced at the moderate OE dose (LFC 0.90) together with the normally gut-restricted gel-forming mucin MUC2 (LFC 1.34). MUC5B trended down only at the high dose (LFC -0.79, Padj = 1.0e-1). The resulting MUC5AC/MUC5B ratio, which governs the viscoelastic properties of airway mucus, rose significantly at the moderate dose (P = 3.19e-2) and further at the high dose (P = 2.68e-2), both by two-tailed paired t test against mock-treated cultures. A high-dose-specific induction of mucin O-glycosylation enzymes (GALNT3, 5, 6, 7, 12 and GCNT3) accompanied the ratio shift. Mucin mRNA values are log2 fold changes; the ratio itself is reported only as a significant increase, with no ratio value, so no QuantityValue is recorded for it.

Exposure conditions

ConditionAgentConcentrationDuration
Mock extract control (blank filter extract), two apical stimulations 24 h apart
EXPOSURE:montgomery-mock-48h
— — 48 hour
PM2.5 organic extract 0.45 ug/cm2 (moderate dose), two apical stimulations 24 h apart
EXPOSURE:montgomery-oe-mod-48h
fine respirable suspended particulate matter
ENVO:01000415
0.45 microgram per square centimeter 48 hour
PM2.5 organic extract 4.5 ug/cm2 (high dose), two apical stimulations 24 h apart
EXPOSURE:montgomery-oe-high-48h
fine respirable suspended particulate matter
ENVO:01000415
4.5 microgram per square centimeter 48 hour

Outputs

GroupOutputDescription
control Gel-forming mucin transcripts in paired mock-stimulated cultures
GCM:montgomery-mucin-transcripts-acute-output-mock · under EXPOSURE:montgomery-mock-48h
Paired mock control; the paper reports mucin responses only as LFCs and ratio changes against it.
treated Gel-forming mucin transcripts at the moderate OE dose
GCM:montgomery-mucin-transcripts-acute-output-oe-mod · under EXPOSURE:montgomery-oe-mod-48h
muc5ac_mrna_expression is the log2 fold change (LFC = 0.90) versus paired mock cultures. MUC2 was induced at LFC 1.34 in the same comparison; the schema has no MUC2 slot, so that value is kept in this description. The MUC5AC/MUC5B ratio rose significantly at this dose (P = 3.19e-2, two-tailed paired t test).
muc5ac mrna expression: 0.90 (single value; n=12)
treated Gel-forming mucin transcripts at the high OE dose
GCM:montgomery-mucin-transcripts-acute-output-oe-high · under EXPOSURE:montgomery-oe-high-48h
muc5b_mrna_expression is the log2 fold change (LFC = -0.79, Padj = 1.0e-1, a trend rather than a significant change) versus paired mock cultures. MUC5AC induction was maintained at this dose and the MUC5AC/MUC5B ratio rose further (P = 2.68e-2, two-tailed paired t test); the paper gives no separate high-dose MUC5AC LFC in the cached text.
muc5b mrna expression: -0.79 (single value; n=5)

Evidence

MUC5AC(mucin 5AC), was strongly induced by OE stimulation, as was another gel-forming mucin,MUC2(mucin 2), which is normally expressed in the gut and lowly expressed in the airway (LFC, 0.90 and 1.34, respectively; Table E2)
SUPPORT IN VITRO PMID:32275839

Source of the MUC5AC LFC of 0.90 and the MUC2 LFC of 1.34 recorded on the moderate-dose output record.

we observed a trend toward decreased expression of the other major gel-forming mucin,MUC5B(mucin 5B), only with the high OE dose
SUPPORT IN VITRO PMID:32275839

Source of the MUC5B decrease recorded on the high-dose output record, and of its status as a trend (Padj = 1.0e-1) rather than a significant change.

It is notable that a significant increase in theMUC5AC/MUC5Bratio with moderate OE dose
SUPPORT IN VITRO PMID:32275839

States the significant increase in the MUC5AC/MUC5B ratio at the moderate dose, which this assay records qualitatively because the paper gives only its p-values.

suggesting an important relationship between OE stimulation and alteration of mucus properties
SUPPORT IN VITRO PMID:32275839

The paper's interpretation of the mucin ratio shift, supporting the link from this assay to the mucin/goblet key event.

GCM:montgomery-mucin-cells-chronic

MUC5AC+ and MUC5B+ cells and mucin transcripts - chronic OE stimulation

After five days of repeat high-OE stimulation, MUC5AC mRNA rose (LFC 1.72, P = 1.27e-2; IL-13 benchmark LFC 3.71, P = 8.86e-3) while MUC5B trended down (LFC -0.72, P = 9.74e-2; IL-13 LFC -5.24, P = 2.55e-2). Immunofluorescence for the two gel-forming mucins showed more MUC5AC+ cells in all four donor pairs (FC 2.88, P = 3.19e-2) and fewer MUC5B+ cells in all four (FC 0.74, P = 8.84e-2). AB-PAS staining of the same cultures is recorded separately as GCM:montgomery-abpas-chronic. The cell-count fold changes and their p-values are in response_comparisons; the transcript values here are log2 fold changes.

Exposure conditions

ConditionAgentConcentrationDuration
Media control, five apical treatments every 24 h
EXPOSURE:montgomery-media-control-chronic
— — 120 hour
PM2.5 organic extract, high dose (Yuba City sample), five apical stimulations every 24 h
EXPOSURE:montgomery-oe-high-chronic
fine respirable suspended particulate matter
ENVO:01000415
— 120 hour
IL-13 10 ng/ml apical and basolateral, five treatments every 24 h (mucus metaplasia benchmark)
EXPOSURE:montgomery-il13-chronic
— — 120 hour

Outputs

GroupOutputDescription
control MUC5AC+ and MUC5B+ cells in paired media control cultures
GCM:montgomery-mucin-cells-chronic-output-control · under EXPOSURE:montgomery-media-control-chronic
Paired mock/media control. The paper reports cell counts only as fold changes against this control, so no absolute count is recorded here.
treated MUC5AC+ and MUC5B+ cells after chronic OE stimulation
GCM:montgomery-mucin-cells-chronic-output-oe · under EXPOSURE:montgomery-oe-high-chronic
muc5ac_mrna_expression and muc5b_mrna_expression are log2 fold changes (LFC 1.72, P = 1.27e-2; LFC -0.72, P = 9.74e-2 respectively) versus paired media control. The cell-count fold changes in MUC5AC+ cells (FC 2.88) and MUC5B+ cells (FC 0.74) are recorded in response_comparisons with their p-values.
muc5ac mrna expression: 1.72 (single value) muc5b mrna expression: -0.72 (single value)
treated Mucin transcripts after chronic IL-13 stimulation (benchmark)
GCM:montgomery-mucin-cells-chronic-output-il13 · under EXPOSURE:montgomery-il13-chronic
muc5ac_mrna_expression and muc5b_mrna_expression are log2 fold changes (LFC 3.71, P = 8.86e-3; LFC -5.24, P = 2.55e-2) versus paired media control, for the IL-13 mucus metaplasia benchmark.
muc5ac mrna expression: 3.71 (single value) muc5b mrna expression: -5.24 (single value)

Evidence

we found an increase in MUC5AC+cells with chronic OE stimulation for all four donors
SUPPORT IN VITRO PMID:32275839

Source of the increase in MUC5AC+ cells recorded on the chronic OE output record, including that it held in every donor pair examined.

cultures for all four donors exhibited a decrease in MUC5B+cells with chronic OE exposure
SUPPORT IN VITRO PMID:32275839

Source of the decrease in MUC5B+ cells recorded on the same output record.

These data demonstrate that chronic OE stimulation induces simultaneous expansion and reduction of MUC5AC+and MUC5B+mucus secretory cells, respectively, resulting in corresponding changes in secretion of these mucins.
SUPPORT IN VITRO PMID:32275839

The paper's summary of the reciprocal MUC5AC/MUC5B cell and secretion changes that this assay and the secretion assay record.

GCM:montgomery-abpas-chronic

AB-PAS mucin-positive cells - chronic OE stimulation

Alcian blue-periodic acid-Schiff staining of culture sections found more mucin-positive cells after chronic OE stimulation in three of the four donor pairs examined (average fold change 2.01, P = 6.52e-2). The paper attributes the extra staining primarily to MUC5AC. The fold change and p-value are in response_comparisons; the paper reports no absolute mucin-positive cell percentage.

Exposure conditions

ConditionAgentConcentrationDuration
Media control, five apical treatments every 24 h
EXPOSURE:montgomery-media-control-chronic
— — 120 hour
PM2.5 organic extract, high dose (Yuba City sample), five apical stimulations every 24 h
EXPOSURE:montgomery-oe-high-chronic
fine respirable suspended particulate matter
ENVO:01000415
— 120 hour

Outputs

GroupOutputDescription
control AB-PAS mucin-positive cells in paired mock-stimulated cultures
GCM:montgomery-abpas-chronic-output-control · under EXPOSURE:montgomery-media-control-chronic
Paired mock control; the paper reports only the fold change against it.
treated AB-PAS mucin-positive cells after chronic OE stimulation
GCM:montgomery-abpas-chronic-output-oe · under EXPOSURE:montgomery-oe-high-chronic
Increased in three of four donor pairs, average fold change 2.01 (P = 6.52e-2). Recorded as COMP:montgomery-abpas-chronic in response_comparisons; no absolute percentage is reported.

Evidence

found higher numbers of mucin-positive cells in chronic OE-stimulated versus mock-stimulated cultures for three of the four donor pairs examined
SUPPORT IN VITRO PMID:32275839

Source of the AB-PAS finding this assay records, including that it held in three of four donor pairs; the average fold change of 2.01 and P of 6.52e-2 follow in the same sentence of the cached text.

GCM:montgomery-mucin-secretion-chronic

ATP-induced MUC5AC and MUC5B secretion - chronic OE stimulation

In an ATP-induced mucus secretion assay read by colorimetric ELISA in cultures from five donors, chronic OE raised total secreted MUC5AC 2.2-fold (P = 1.54e-2, comparable with the 3.87-fold rise under the IL-13 benchmark, P = 3.85e-2) and lowered MUC5B secretion to 0.81-fold (P = 3.59e-3; IL-13 0.70-fold, P = 5.20e-2). All four fold changes are recorded in response_comparisons with their p-values; the paper reports no absolute mucin concentrations.

Exposure conditions

ConditionAgentConcentrationDuration
Media control, five apical treatments every 24 h
EXPOSURE:montgomery-media-control-chronic
— — 120 hour
PM2.5 organic extract, high dose (Yuba City sample), five apical stimulations every 24 h
EXPOSURE:montgomery-oe-high-chronic
fine respirable suspended particulate matter
ENVO:01000415
— 120 hour
IL-13 10 ng/ml apical and basolateral, five treatments every 24 h (mucus metaplasia benchmark)
EXPOSURE:montgomery-il13-chronic
— — 120 hour

Outputs

GroupOutputDescription
control ATP-induced mucin secretion in paired media control cultures
GCM:montgomery-mucin-secretion-chronic-output-control · under EXPOSURE:montgomery-media-control-chronic
Paired media control; secretion is reported only as a fold change against it.
treated ATP-induced mucin secretion after chronic OE stimulation
GCM:montgomery-mucin-secretion-chronic-output-oe · under EXPOSURE:montgomery-oe-high-chronic
MUC5AC secretion 2.2-fold up (P = 1.54e-2) and MUC5B secretion 0.81-fold (P = 3.59e-3) versus paired control, both recorded in response_comparisons. No absolute secreted mucin concentration is reported.
treated ATP-induced mucin secretion after chronic IL-13 stimulation (benchmark)
GCM:montgomery-mucin-secretion-chronic-output-il13 · under EXPOSURE:montgomery-il13-chronic
MUC5AC secretion 3.87-fold up (P = 3.85e-2) and MUC5B secretion 0.70-fold (P = 5.20e-2) versus paired control, for the IL-13 benchmark.

Evidence

Chronic OE induced a 2.2-fold increase in total secreted MUC5AC
SUPPORT IN VITRO PMID:32275839

Source of the 2.2-fold increase in secreted MUC5AC recorded for the chronic OE condition.

we observed a significant decrease in the secretion of MUC5B with chronic OE
SUPPORT IN VITRO PMID:32275839

Source of the decrease in secreted MUC5B recorded for the same condition (FC 0.81, P = 3.59e-3 in the same sentence of the cached text).

FOXJ assays

FOXJ:montgomery-ciliary-programs-high-oe

Ciliated cell expression programs - high acute OE dose

Downregulated DEGs specific to the high OE dose were dominated by cilia development and function terms, and were highly enriched for ciliated cell marker genes (Padj = 3.57e-118). Mean expression of the ciliary movement (P = 3.05e-3) and ciliary assembly (P = 4.20e-4) GO modules fell only at the high dose, by two-tailed paired t test. The canonical ciliated cell differentiation transcription factors MCIDAS, MYB, TP73, RFX2, RFX3 and FOXJ1 were consistently decreased. The cached text gives no per-gene LFC for these transcription factors at this dose, so no value is recorded on the output record.

Exposure conditions

ConditionAgentConcentrationDuration
Mock extract control (blank filter extract), two apical stimulations 24 h apart
EXPOSURE:montgomery-mock-48h
— — 48 hour
PM2.5 organic extract 4.5 ug/cm2 (high dose), two apical stimulations 24 h apart
EXPOSURE:montgomery-oe-high-48h
fine respirable suspended particulate matter
ENVO:01000415
4.5 microgram per square centimeter 48 hour

Outputs

GroupOutputDescription
control Ciliated cell programs in paired mock-stimulated cultures
FOXJ:montgomery-ciliary-programs-high-oe-output-mock · under EXPOSURE:montgomery-mock-48h
Paired mock control; module expression and transcription factor changes are reported only against it.
treated Ciliated cell programs at the high OE dose
FOXJ:montgomery-ciliary-programs-high-oe-output-oe-high · under EXPOSURE:montgomery-oe-high-48h
Ciliary assembly (P = 4.20e-4) and ciliary movement (P = 3.05e-3) module mean expression significantly downregulated; ciliated cell marker enrichment among downregulated DEGs Padj = 3.57e-118; MCIDAS, MYB, TP73, RFX2, RFX3 and FOXJ1 consistently decreased. No per-gene effect size is reported in the cached text, so no value is recorded.

Evidence

Enrichment analysis of downregulated genes yielded multiple terms specific to the high OE dose, the majority of which were related to the development and function of cilia
SUPPORT IN VITRO PMID:32275839

Establishes that the ciliary programs are the high-dose-specific downregulated signature this assay records.

exhibited significant downregulation in expression only with high OE dose
SUPPORT IN VITRO PMID:32275839

Covers the significant fall in the ciliary movement and ciliary assembly module means, and that it was confined to the high dose.

Supporting this loss in ciliated cell gene expression, we found canonical TFs controlling ciliated cell differentiation (MCIDAS,MYB,TP73,RFX2,RFX3, andFOXJ1) were consistently decreased with high OE dose
SUPPORT IN VITRO PMID:32275839

Names the ciliogenesis transcription factors whose decrease this assay records as decreased ciliogenesis; copied exactly as cached, where the gene symbols run together.

Together, these data show that high OE dose mediates the same mucus secretory changes observed with moderate OE dose but also downregulates ciliary expression programs.
SUPPORT IN VITRO PMID:32275839

The paper's own summary that the ciliary downregulation is an additional, dose-dependent effect on top of the mucus secretory response.

FOXJ:montgomery-foxj1-chronic

FOXJ1 expression and nuclear localization - chronic OE stimulation

Chronic OE stimulation lowered FOXJ1 transcript levels (LFC -0.36, P = 1.92e-2; IL-13 benchmark LFC -1.15, P = 6.34e-3) and, by confocal immunofluorescence in three donors, produced a 75% average decrease in FOXJ1+ nuclei versus mock (P = 1.20e-2) - more pronounced than the nonsignificant 40% decrease under IL-13 (P = 1.02e-1). Ciliary structure and abundance were relatively consistent across conditions, although acetylated alpha-tubulin staining appeared weaker in OE-stimulated cultures, so the paper reads this as loss of nuclear FOXJ1 rather than loss of ciliated cells. The percent decreases are recorded in response_comparisons.

Exposure conditions

ConditionAgentConcentrationDuration
Media control, five apical treatments every 24 h
EXPOSURE:montgomery-media-control-chronic
— — 120 hour
PM2.5 organic extract, high dose (Yuba City sample), five apical stimulations every 24 h
EXPOSURE:montgomery-oe-high-chronic
fine respirable suspended particulate matter
ENVO:01000415
— 120 hour
IL-13 10 ng/ml apical and basolateral, five treatments every 24 h (mucus metaplasia benchmark)
EXPOSURE:montgomery-il13-chronic
— — 120 hour

Outputs

GroupOutputDescription
control FOXJ1 in paired mock/media control cultures
FOXJ:montgomery-foxj1-chronic-output-control · under EXPOSURE:montgomery-media-control-chronic
Paired control; FOXJ1 is reported only as an LFC and as a percent decrease in FOXJ1+ nuclei against it.
treated FOXJ1 after chronic OE stimulation
FOXJ:montgomery-foxj1-chronic-output-oe · under EXPOSURE:montgomery-oe-high-chronic
foxj1_mrna_expression is the log2 fold change (LFC = -0.36, P = 1.92e-2) versus paired control. FOXJ1+ nuclei fell by 75% on average (P = 1.20e-2, n = 3 donors); that percent change is recorded in response_comparisons rather than as an absolute FOXJ1+ percentage, which the paper does not report.
foxj1 mrna expression: -0.36 (single value)
treated FOXJ1 after chronic IL-13 stimulation (benchmark)
FOXJ:montgomery-foxj1-chronic-output-il13 · under EXPOSURE:montgomery-il13-chronic
foxj1_mrna_expression is the log2 fold change (LFC = -1.15, P = 6.34e-3) versus paired control. FOXJ1+ nuclei fell by a nonsignificant 40% (P = 1.02e-1).
foxj1 mrna expression: -1.15 (single value)

Evidence

OE-stimulated cultures displayed a 75% average decrease in FOXJ1+nuclei compared with mock-treated cultures
SUPPORT IN VITRO PMID:32275839

Source of the 75% decrease in FOXJ1+ nuclei recorded for the chronic OE condition (P = 1.20e-2 in the same sentence of the cached text).

as well as downregulation ofFOXJ1(forkhead box J1)
SUPPORT IN VITRO PMID:32275839

Source of the FOXJ1 transcript downregulation under chronic OE and IL-13 recorded on the two treated output records.

The lack of nuclear FOXJ1 in ciliated cells from chronic OE-stimulated cultures is consistent with the decrease in ciliated cell gene expression observed in our transcriptome analysis.
SUPPORT IN VITRO PMID:32275839

Ties the chronic nuclear FOXJ1 loss to the acute high-dose ciliary transcriptional downregulation, which is why both assays inform on the same altered ciliogenesis key event.

Response comparisons

COMP:montgomery-muc5ac-cells-chronic

MUC5AC+ cells, chronic OE vs mock

Increase seen in all four donor pairs examined. Figure 5B quantifies the number of MUC5AC+ cells by immunofluorescence, so the compared measurement is a cell count (of MUC5AC+ mucus secretory cells), not a protein expression level.

measurement: goblet_cell_count direction: increased type: fold change value: 2.88 fold change (; n=4) derivation: reported in paper from assay: GCM:montgomery-mucin-cells-chronic

Statistical test: paired, one-tailed t test

COMP:montgomery-muc5b-cells-chronic

MUC5B+ cells, chronic OE vs mock

Decrease seen in all four donor pairs examined; P above the 0.05 threshold. Figure 5B quantifies the number of MUC5B+ cells by immunofluorescence, so the compared measurement is a cell count (of MUC5B+ mucus secretory cells), not a protein expression level.

measurement: goblet_cell_count direction: decreased type: fold change value: 0.74 fold change (; n=4) derivation: reported in paper from assay: GCM:montgomery-mucin-cells-chronic

Statistical test: paired, one-tailed t test

COMP:montgomery-abpas-chronic

AB-PAS mucin-positive cells, chronic OE vs mock

Average fold change across four donor pairs; three of the four increased. P above the 0.05 threshold.

measurement: goblet_cell_percentage direction: increased type: fold change value: 2.01 fold change (mean; n=4) derivation: reported in paper from assay: GCM:montgomery-abpas-chronic

Statistical test: paired, one-tailed t test

COMP:montgomery-muc5ac-secretion-chronic

ATP-induced MUC5AC secretion, chronic OE vs control

measurement: mucin_secretion_rate direction: increased type: fold change value: 2.2 fold change (; n=5) derivation: reported in paper from assay: GCM:montgomery-mucin-secretion-chronic

Statistical test: paired, one-tailed t test

COMP:montgomery-muc5b-secretion-chronic

ATP-induced MUC5B secretion, chronic OE vs control

measurement: mucin_secretion_rate direction: decreased type: fold change value: 0.81 fold change (; n=5) derivation: reported in paper from assay: GCM:montgomery-mucin-secretion-chronic

Statistical test: paired, one-tailed t test

COMP:montgomery-muc5ac-secretion-il13

ATP-induced MUC5AC secretion, chronic IL-13 vs control (benchmark)

IL-13 benchmark for metaplastic expansion of mucus secretory cells, run on the same donors.

measurement: mucin_secretion_rate direction: increased type: fold change value: 3.87 fold change (; n=5) derivation: reported in paper from assay: GCM:montgomery-mucin-secretion-chronic

Statistical test: paired, one-tailed t test

COMP:montgomery-spdef-protein-chronic

SPDEF protein, chronic OE vs control

Western blot band intensity normalized to actin, five independent donors.

measurement: protein_level direction: increased type: fold change value: 1.5 fold change (; n=5) derivation: reported in paper from assay: GE:montgomery-spdef-chronic-qpcr

Statistical test: paired, one-tailed t test

COMP:montgomery-foxj1-nuclei-chronic

FOXJ1+ nuclei, chronic OE vs mock

Average percent decrease in FOXJ1+ nuclei by confocal immunofluorescence in cultures from three donors.

measurement: foxj1_positive_cell_percentage direction: decreased type: percent change value: 75 percent (mean; n=3) derivation: reported in paper from assay: FOXJ:montgomery-foxj1-chronic

Statistical test: paired, one-tailed t test

COMP:montgomery-foxj1-nuclei-il13

FOXJ1+ nuclei, chronic IL-13 vs mock (benchmark)

Nonsignificant average decrease under the IL-13 benchmark, less pronounced than under chronic OE.

measurement: foxj1_positive_cell_percentage direction: decreased type: percent change value: 40 percent (mean; n=3) derivation: reported in paper from assay: FOXJ:montgomery-foxj1-chronic

Statistical test: paired, one-tailed t test

Key-event relationships

KER:montgomery-ahr-to-il1

AhR pathway activation leads to IL-1 inflammatory program activation

The paper places AHR signaling activation by PM2.5 PAHs as the early, central event underlying the wider epithelial response, with IL1A and IL1B as the hub genes of the resulting inflammatory network.

which in turn initiates a mucus secretory program in the airway epithelium
SUPPORT IN VITRO PMID:32275839

Closes the paper's summary sentence that moderate OE exposure triggers AHR signaling and IL-1-mediated inflammation, placing the two molecular events on one chain; the paper states co-occurrence and network centrality, not a perturbation experiment, so evidence_support is moderate.

TheCYP1A1,IL1A, andIL1Bgenes were shared by multiple metagroups and exhibited especially high betweenness centrality, indicating the likely critical nature of these genes in the transcriptional response to OE stimulation.
SUPPORT IN VITRO PMID:32275839

The network evidence placing the AHR marker CYP1A1 and the IL-1 cytokines in one connected response.

KER:montgomery-il1-to-goblet

IL-1 inflammatory program activation leads to goblet cell hyperplasia

The paper's central mechanistic claim: the IL-1-driven inflammatory network initiates the mucus secretory program, whose transcription factors SPDEF and FOXA3 drive mucus metaplasia, confirmed cellularly by the chronic exposure model.

which in turn initiates a mucus secretory program in the airway epithelium
SUPPORT IN VITRO PMID:32275839

The paper's statement that the AHR- and IL-1-driven response initiates the mucus secretory program; the chronic model then shows the cellular hyperplasia, but no IL-1 blockade experiment is reported, so evidence_support is moderate.

These data demonstrate that chronic OE stimulation induces simultaneous expansion and reduction of MUC5AC+and MUC5B+mucus secretory cells, respectively, resulting in corresponding changes in secretion of these mucins.
SUPPORT IN VITRO PMID:32275839

The cellular-level confirmation that the transcriptional mucus secretory program ends in an expanded MUC5AC+ secretory compartment and altered mucin secretion.

Protocols

PROTOCOL:montgomery-extract-prep-001

PM2.5 collection, fractionation and chemical characterization

PM2.5 collected on 47-mm polytetrafluoroethylene filters at three California monitoring sites in 2011, pooled by region and fractionated into water-soluble (WE) and organic (OE) extracts. WE species quantified by inductively coupled plasma mass spectrometry and ion chromatography; OE PAH species by gas chromatography-mass spectrometry. Blank filters were extracted to produce the mock extract controls used for stimulations.

Equipment: 47-mm polytetrafluoroethylene filters; Inductively coupled plasma mass spectrometer; Ion chromatograph; Gas chromatograph-mass spectrometer

PROTOCOL:montgomery-ali-stim-001

Nasal AEC air-liquid interface culture and apical extract stimulation

Primary nasal AECs expanded and differentiated at air-liquid interface. On mucociliary differentiation (Day 28-32 of ALI culture) cultures were washed with PBS and apically treated with mock extract or PM2.5 extract in a final volume of 20 ul culture media; the wash and stimulation were repeated at 24 hours and RNA was collected 24 hours later. For chronic experiments the wash and stimulation were repeated every 24 hours for five stimulations, with a high OE dose or 10 ng/ml IL-13.

Equipment: Transwell inserts; ALI culture media; RNA lysis buffer (Zymo Research) with 40 mM DTT

PROTOCOL:montgomery-transcriptome-001

Whole transcriptome RNA-seq of stimulated ALI cultures

KAPA mRNA HyperPrep (Roche) whole transcriptome libraries from 250 ng RNA per sample with 12 cycles of amplification, sequenced on the Illumina NovaSeq 6000. Paired differential expression analysis between mock-stimulated and extract-stimulated cultures from the same donor; DEG enrichment tested with Enrichr against GO/KEGG/Reactome and against scRNA-seq-derived cell type marker lists, with P values corrected for multiple testing. Networks built with FGNet and GeneTerm Linker.

Equipment: KAPA mRNA HyperPrep kit (Roche); Illumina NovaSeq 6000

PROTOCOL:montgomery-qpcr-chronic-001

Quantitative PCR of chronically stimulated cultures

Quantitative PCR of chronic OE- and IL-13-stimulated cultures against paired mock/media controls. The paper places the detailed qPCR conditions in its online data supplement, which is not part of the cached article text.

PROTOCOL:montgomery-if-mucin-001

Immunofluorescence labeling for MUC5AC and MUC5B

Immunofluorescence labeling of culture histological sections for the gel-forming mucins MUC5AC and MUC5B with DAPI nuclear counterstain, followed by quantification of MUC5AC+ and MUC5B+ cells. Representative of labeling in cultures from four donors.

Equipment: Fluorescence microscope; Anti-MUC5AC antibody; Anti-MUC5B antibody; DAPI

PROTOCOL:montgomery-if-foxj1-001

Immunofluorescence labeling for FOXJ1 and acetylated alpha-tubulin

Confocal fluorescence microscopy maximum projections of intact epithelial cultures labeled for E-cadherin, acetylated alpha-tubulin (cilia) and FOXJ1, with DAPI nuclear counterstain, followed by quantification of FOXJ1+ nuclei. Representative of labeling in cultures from three donors.

Equipment: Confocal fluorescence microscope; Anti-FOXJ1 antibody; Anti-acetylated alpha-tubulin antibody; Anti-E-cadherin antibody; DAPI

PROTOCOL:montgomery-abpas-staining-001

Alcian blue-periodic acid-Schiff staining of culture sections

Alcian blue-periodic acid-Schiff staining of culture histological sections for mucopolysaccharides/mucins, with quantification of AB-PAS+ cells. Four donor pairs examined.

Equipment: AB-PAS staining reagents; Light microscope

PROTOCOL:montgomery-wb-spdef-001

Western blot for SPDEF protein

Western blot analysis of total protein for SPDEF, quantified by band intensity normalized to actin as a loading control. Representative of data from five independent donors.

Equipment: SDS-PAGE apparatus; Anti-SPDEF antibody; Densitometry imaging system

PROTOCOL:montgomery-mucin-elisa-001

ATP-induced mucin secretion assay with colorimetric ELISA

ATP-induced mucus secretion assay followed by colorimetric ELISA absorbance readings at 490 nm for MUC5AC and MUC5B in the secretions of cultures from five donors.

Equipment: Plate reader (490 nm); MUC5AC ELISA; MUC5B ELISA; ATP stimulation reagent